Author Archives: Fredricko

Educate, Inform & Inspire Global Awareness by Sharing 'Stem Cells Offer Hope'

Posted on by

IRVINE, CA--(Marketwire - Sep 26, 2012) - Stem cell researchers are literally on the brink of developing new treatments for some of the world's most devastating diseases.Each of us is standing at the intersection of real, tangible progress and limitless possibility. We have the opportunity to help transform medicine by supporting stem cell research online.

On October 3, scientists, researchers and supporters will celebrate International Stem Cell Awareness Day. A new interactive website, http://www.StemCellsOfferHope.com, has been launched to share easily digestible factoids and colorful stem cell imagery within social networks.It also features banners and graphics for bloggers to post information and links to share with their community of followers, family and friends on Facebook, Twitter and Pinterest.Bloggers are encouraged to help drive visitors to this website through the use of entries and social media posts.

"This is a critical and historic time for stem cell research," said Peter Donovan, Ph.D., director, Sue & Bill Gross Stem Cell Research Center, UC Irvine. "The act of simply raising awareness about this research is one of the best things people can do to help accelerate the process."

Researchers have been working diligently to unlock the potential of stem cells and have made significant strides since the discovery of a method to grow and duplicate human stem cells less than 15 years ago. Their efforts to develop cures for conditions such as Alzheimer's disease, multiple sclerosis, macular degeneration, Huntington's disease, Parkinson's disease, as well as traumatic brain injuries and paralysis caused by spinal cord injuries are moving forward at a rapid pace.

For more information visit http://www.stemcellsofferhope.com.

About the Sue & Bill Gross Stem Cell Research Center, UC Irvine: The Sue & Bill Gross Stem Cell Research Center, UC Irvine is one of the largest most technologically advanced stem cell research facilities in the world. The center was established in 2010 in part through a $10 million gift from Bill Gross, founder and co-chief investment officer of international investment firm PIMCO, and his wife Sue. For more than 40 years, its team of scientists and multiple research and graduate assistants have worked to unlock the potential of stem cells for treating and curing an estimated 70 major diseases and disorders. The research center has devised new methods for growing stems cells that are 100 percent more effective than previous techniques. Other advances have led to the world's first clinical trial of a human neural stem cell-based therapy for chronic spinal cord injury and the first FDA-approved clinical trial using human embryonic stem cells. The embryonic stem cells are produced from embryos donated for research purposes during fertility treatments. These cells would otherwise be destroyed. For more information, visit stemcell.uci.edu.

Excerpt from:
Educate, Inform & Inspire Global Awareness by Sharing 'Stem Cells Offer Hope'

Educate, Inform & Inspire Global Awareness by Sharing ‘Stem Cells Offer Hope’

Posted on by

IRVINE, CA--(Marketwire - Sep 26, 2012) - Stem cell researchers are literally on the brink of developing new treatments for some of the world's most devastating diseases.Each of us is standing at the intersection of real, tangible progress and limitless possibility. We have the opportunity to help transform medicine by supporting stem cell research online.

On October 3, scientists, researchers and supporters will celebrate International Stem Cell Awareness Day. A new interactive website, http://www.StemCellsOfferHope.com, has been launched to share easily digestible factoids and colorful stem cell imagery within social networks.It also features banners and graphics for bloggers to post information and links to share with their community of followers, family and friends on Facebook, Twitter and Pinterest.Bloggers are encouraged to help drive visitors to this website through the use of entries and social media posts.

"This is a critical and historic time for stem cell research," said Peter Donovan, Ph.D., director, Sue & Bill Gross Stem Cell Research Center, UC Irvine. "The act of simply raising awareness about this research is one of the best things people can do to help accelerate the process."

Researchers have been working diligently to unlock the potential of stem cells and have made significant strides since the discovery of a method to grow and duplicate human stem cells less than 15 years ago. Their efforts to develop cures for conditions such as Alzheimer's disease, multiple sclerosis, macular degeneration, Huntington's disease, Parkinson's disease, as well as traumatic brain injuries and paralysis caused by spinal cord injuries are moving forward at a rapid pace.

For more information visit http://www.stemcellsofferhope.com.

About the Sue & Bill Gross Stem Cell Research Center, UC Irvine: The Sue & Bill Gross Stem Cell Research Center, UC Irvine is one of the largest most technologically advanced stem cell research facilities in the world. The center was established in 2010 in part through a $10 million gift from Bill Gross, founder and co-chief investment officer of international investment firm PIMCO, and his wife Sue. For more than 40 years, its team of scientists and multiple research and graduate assistants have worked to unlock the potential of stem cells for treating and curing an estimated 70 major diseases and disorders. The research center has devised new methods for growing stems cells that are 100 percent more effective than previous techniques. Other advances have led to the world's first clinical trial of a human neural stem cell-based therapy for chronic spinal cord injury and the first FDA-approved clinical trial using human embryonic stem cells. The embryonic stem cells are produced from embryos donated for research purposes during fertility treatments. These cells would otherwise be destroyed. For more information, visit stemcell.uci.edu.

Excerpt from:
Educate, Inform & Inspire Global Awareness by Sharing 'Stem Cells Offer Hope'

Dance for Parkinson's kicks off its fourth year with visit from Mark Morris Dance Group

Posted on by

SEATTLE, Sept. 24, 2012 /PRNewswire/ -- Laughter and joy are classroom staples at a popular dance class that combines live music and dance instruction from world-class professional dancers. Dance for Parkinson's inspires those living with Parkinson's disease (PD) to explore the benefits of dance and movement with others who share some of the challenging symptoms of the disease.

Dance for Parkinson's was initiated in the Northwest by Seattle Theatre Group in partnership with EvergreenHealth and Spectrum Dance Theater, later expanding to include Northwest Parkinson's Foundation and Des Moines Senior Center. Classes are offered in Kirkland (Peter Kirk Community Center), Seattle (Garfield Community Center) and Des Moines (Des Moines Senior Center).

EvergreenHealth is one of the first healthcare organizations in the nation to provide this program, hosting a quarterly series of classes each year since 2009.

Classes are free of charge, are led by professional dancers, and engage students in dance styles such as ballet, jazz, contemporary, tap and world dance to address PD-specific concerns such as balance, flexibility, coordination, isolation and depression. No dance experience is required, and the fun, uplifting classes are a welcome respite from the stress of Parkinson's on participants and caregivers.

"The ability to help Parkinson's patients reclaim independent movement through creative dance is effective therapy not just physically, but emotionally," said Dr. Juan Aragon, Director of Medical Specialties and Medical Staff at EvergreenHealth. "Dancers leave the class glowing and truly inspired, which is beautiful to see in our patients."

A new 8-week fall season will kick-off with a special visit from David Leventhal, former principal dancer for Mark Morris Dance Group from 1997-2011 and Program Manager for Dance for PD in New York City.

Dance for PD was born of collaboration between Mark Morris Dance Group and Brooklyn Parkinson's Group Executive Director Olie Westheimer in 2001, with global expansion taking off in 2005. Today, classes are held across the United States and the world, including Tel Aviv and Auckland. A Seattle native, Mark Morris is the Artistic Director of the internationally renowned Mark Morris Dance Group in Brooklyn, New York.

"Although participants from all over the world tell us they find elements of the class therapeutic, the primary goal of our program is for people to enjoy dance for dancing's sake in a group settingand to explore the range of physical and creative possibilities that are still very much open to them," said David Leventhal.

Leventhal is visiting Seattle to host a seminar for health professionals, physical therapists, social workers, senior program professionals and any member of the public who is interested in learning more about the unique approach of this community arts and health program. The seminar will be held at Garfield Community Center on Oct. 4, 10 a.m.-5 p.m., and will incorporate a live class to demonstrate the benefits of the program for participants.

"We're so pleased to see the Mark Morris Dance Group's initial partnership with Seattle Theatre Group, EvergreenHealth and Spectrum Dance Theater blossom into such a strong, high-quality program with multiple sites reaching multiple districts in the Seattle area," said Leventhal. "The success of the Seattle program shows just how effective arts and health programs can be when organizations that share an innovative vision work together collaboratively."

Follow this link:
Dance for Parkinson's kicks off its fourth year with visit from Mark Morris Dance Group

Dance for Parkinson’s kicks off its fourth year with visit from Mark Morris Dance Group

Posted on by

SEATTLE, Sept. 24, 2012 /PRNewswire/ -- Laughter and joy are classroom staples at a popular dance class that combines live music and dance instruction from world-class professional dancers. Dance for Parkinson's inspires those living with Parkinson's disease (PD) to explore the benefits of dance and movement with others who share some of the challenging symptoms of the disease.

Dance for Parkinson's was initiated in the Northwest by Seattle Theatre Group in partnership with EvergreenHealth and Spectrum Dance Theater, later expanding to include Northwest Parkinson's Foundation and Des Moines Senior Center. Classes are offered in Kirkland (Peter Kirk Community Center), Seattle (Garfield Community Center) and Des Moines (Des Moines Senior Center).

EvergreenHealth is one of the first healthcare organizations in the nation to provide this program, hosting a quarterly series of classes each year since 2009.

Classes are free of charge, are led by professional dancers, and engage students in dance styles such as ballet, jazz, contemporary, tap and world dance to address PD-specific concerns such as balance, flexibility, coordination, isolation and depression. No dance experience is required, and the fun, uplifting classes are a welcome respite from the stress of Parkinson's on participants and caregivers.

"The ability to help Parkinson's patients reclaim independent movement through creative dance is effective therapy not just physically, but emotionally," said Dr. Juan Aragon, Director of Medical Specialties and Medical Staff at EvergreenHealth. "Dancers leave the class glowing and truly inspired, which is beautiful to see in our patients."

A new 8-week fall season will kick-off with a special visit from David Leventhal, former principal dancer for Mark Morris Dance Group from 1997-2011 and Program Manager for Dance for PD in New York City.

Dance for PD was born of collaboration between Mark Morris Dance Group and Brooklyn Parkinson's Group Executive Director Olie Westheimer in 2001, with global expansion taking off in 2005. Today, classes are held across the United States and the world, including Tel Aviv and Auckland. A Seattle native, Mark Morris is the Artistic Director of the internationally renowned Mark Morris Dance Group in Brooklyn, New York.

"Although participants from all over the world tell us they find elements of the class therapeutic, the primary goal of our program is for people to enjoy dance for dancing's sake in a group settingand to explore the range of physical and creative possibilities that are still very much open to them," said David Leventhal.

Leventhal is visiting Seattle to host a seminar for health professionals, physical therapists, social workers, senior program professionals and any member of the public who is interested in learning more about the unique approach of this community arts and health program. The seminar will be held at Garfield Community Center on Oct. 4, 10 a.m.-5 p.m., and will incorporate a live class to demonstrate the benefits of the program for participants.

"We're so pleased to see the Mark Morris Dance Group's initial partnership with Seattle Theatre Group, EvergreenHealth and Spectrum Dance Theater blossom into such a strong, high-quality program with multiple sites reaching multiple districts in the Seattle area," said Leventhal. "The success of the Seattle program shows just how effective arts and health programs can be when organizations that share an innovative vision work together collaboratively."

Follow this link:
Dance for Parkinson's kicks off its fourth year with visit from Mark Morris Dance Group

Celebrities drawing attention to multiple sclerosis a sign of hope for N.J. patients

Posted on by

Quick: What do Ozzy Osbourne and Mitt Romney have in common?

DON SMITH/STAFF PHOTOGRAPHER

Patients work out at Holy Name Medical Center's MS Center.

The former is a rocker who once bit the head off a bat and starred in his own reality television series, while the latter was a titan of Bain Capital and now Republican candidate for president.

Both are part of the 1 percent.

But beyond that, each has a family member diagnosed with multiple sclerosis.

For Ozzy, it's son Jack Osbourne, 26, who learned in June that he has MS after partial blindness in his right eye led him to seek a doctor's care. Word of the diagnosis came two weeks after his fiance, Lisa Stelly, gave birth to their daughter.

"I was just angry and frustrated and kept thinking, 'Why now?'x'' he told People magazine.

For Mitt, it's wife Ann Romney, 63, whose Republican National Convention speech, aimed at humanizing the candidate, scoffed at the notion that theirs is a "storybook marriage." Those storybooks, she said, "never seemed to have chapters called 'MS' or 'Breast Cancer.'x"

Her husband's steadfastness through her illnesses, she implied, provided ample evidence to voters that "this man will not let us down."

Read more:
Celebrities drawing attention to multiple sclerosis a sign of hope for N.J. patients

Easing multiple sclerosis symptoms with food

Posted on by

For multiple sclerosis (MS) sufferers, symptoms like numbness, fatigue and difficulty walking can be debilitating but changing what they eat can have a big impact on the quality of their lives.

The National MS Society website advises a diet thats low in saturated fats and high in omega-3 fatty acids.

A two-year study of 312 MS patients revealed that people who ingested 10 grams of fish oil each day had less progression of the debilitating disease than those who did not take supplements.

You can take a supplement, but it is always a good idea to incorporate whole foods into your diet, said Dr. Manny Alvarez, senior managing health editor at FoxNews.com.

Walnuts, flaxseed and cod liver oil are excellent sources of omega-3 fatty acids, as well as fatty fish such as salmon.

According to the National MS Society, three grams of omega-3 fatty acids per day is considered safe, but you should talk to your doctor before making any changes to your diet.

Originally posted here:
Easing multiple sclerosis symptoms with food

ANN ARBOR: District library to host Lewy Body Dementia talk Oct. 16

Posted on by

The Ann Arbor District Library will host an informational program about http://www.lbda.org">Lewy Body Dementia from 7 to 8:30 p.m. Oct. 16 in the Multi-Purpose Room of the Downtown Library, 343 S. Fifth Ave., in Ann Arbor.

The talk will feature local medical professionals and people helping loved ones cope with the disease.

Washtenaw County resident Tamara Real watched helplessly for two years as her husband, Carl Rinne, withdrew from life before he was diagnosed with Lewy Body Dementia in in 2010.

Real's experience is not an unusual one among Lewy Body Dementia caregivers, though she was not aware of how prevalent the problem was at first.

Then Real found the Lewy Body Dementia Association and learned that most Lewy Body Dementia families are faced with educating not just their friends and families about Lewy Body Dementia, but sometimes physicians and nurses as well.

When LBDA launched its nationwide October awareness movement, "A Month to Remember," in order to raise Lewy Body Dementia awareness, Real volunteered.

Lewy body dementia is a progressive brain disease that is misdiagnosed more often than not.

In a study by the Lewy Body Dementia Association, family caregivers reported that Lewy Body Dementia was not the first diagnosis in 78 percent of cases.

Despite an estimated patient population of 1.3 million people in the U.S., Lewy Body Dementia is most often misdiagnosed as Alzheimer's disease, Parkinson's disease or a psychiatric disorder.

"Given the growing population of older Americans, at some point in your life Lewy Body Dementia will likely affect someone you know," said Angela Herron, president of LBDA's board of directors, in a news release. Continued...

View original post here:
ANN ARBOR: District library to host Lewy Body Dementia talk Oct. 16

New report highlights innovative approach of the Celtic Nations Autism Partnership

Posted on by

New report highlights innovative approach of the Celtic Nations Autism Partnership

CARDIFF, Wales: A new report by autism charities demonstrated the innovative approaches to improving the lives of people with autism across the North of Ireland, Scotland and Wales.

That's the feeling of many of the charities within the Celtic Nations Autism Partnership (CNAP) and those in the Autism Alliance UK. CNAP spokesman Cathy Maclean said: "The North of Ireland, Scotland and Wales are being particularly dynamic in the way their devolved governments are helping with national autism strategies,"

Arlene Cassidy, CEO of Autism Northern Ireland, commented: "Massive social change takes time but it also takes leadership, consistency and inclusive practice. This was vital in our successful campaign for equality legislation for Autism in Northern Ireland."

Sinn Fin Health spokesperson Councillor Paul Fleming said: "Since the Welsh and Scottish Governments' introduction of an all-age autism strategy, legislation in the North of Ireland now impels all government departments to work together to deliver an all-age autism strategy and financial commitment has been promised for this. Government-funded strategies across the North of Ireland, much like in Scotland and Wales, are making real differences to the autism community and those who support them, especially the many voluntary sector organisations."

"In the future, there is the potential for the Island of Ireland to establish an all-age Autism Research Centre and work in conjunction with NUI Galway's centre for Autism and Neurodevelopment Research, to provide better outcomes for autistic individuals and their families mirroring that which has been established at Cardiff University in Wales, which could increase investment and focus into autism research in Ireland."

(Source: CNAP, July 26, 2012)

Visit link:
New report highlights innovative approach of the Celtic Nations Autism Partnership

Research Lacking on Drugs for Older Children With Autism, Study Finds

Posted on by

MONDAY, Sept. 24 (HealthDay News) -- More and more children are growing up with autism, and although many treatments and interventions are now available, clinical studies on the use of medications in teens and young adults are lacking, according to new research.

"The majority of (older) individuals with autism spectrum disorders appear to be taking medications that we have very little evidence for," said the study's lead author, Dr. Jeremy Veenstra-VanderWeele, medical director of the Treatment and Research Institute for Autism Spectrum Disorders at the Vanderbilt Brain Institute in Nashville, Tenn.

"In the absence of sufficient evidence, parents and people with autism should find a clinician who tells you what's known and unknown about the potential benefits and risks of any medication," he said. "It should be a shared decision-making process."

Results of the study were published online on Sept. 24 in the journal Pediatrics.

Autism spectrum disorders are neurodevelopmental disorders that impair social development and communication. Autism spectrum disorders also may cause repetitive movements and even self-abusive behavior, such as head banging, according to the U.S. National Institute of Neurological Disorders and Stroke (NINDS).

It is estimated that about one in 88 American children has been identified with an autism spectrum disorder

As children with autism age, some do experience significant improvements, according to NINDS, but many do not. There is no cure for autism, although there are many treatments available, including education and behavioral interventions and medications.

Medications usually are used to treat some of the symptoms associated with autism, rather than the core symptoms of the condition, according to background information in the new study. For example, the medication risperidone (brand name Risperdal) may be used to treat behavioral symptoms associated with autism, such as aggression, outbursts and irritability, said Dr. Melissa Nishawala, medical director of the Autism Spectrum Disorders Clinical and Research Program at the NYU Child Study Center in New York City.

"Medications like risperidone and aripiprazole don't address the cause of autism, but they help calm down [people with autism]," Veenstra-VanderWeele said.

For the new study, the researchers reviewed medical literature from 1980 through 2011 to find clinical trials on drugs for people with autism between the ages of 13 and 30 years old. They found eight studies with at least 20 participants. Two investigators independently assessed the quality of the studies.

View original post here:
Research Lacking on Drugs for Older Children With Autism, Study Finds

Girl diagnosed with autism and DiGeorge syndrome memorizes entire Coppelia ballet

Posted on by

(CBS News) It's hard to remember an entire dance routine, but one special girl has committed the entire lead ballet role in Coppelia to memory.

Clara Bergs's parents wrote that they thought their daughter was just dancing ballet moves around the house, until they realized she had memorized an entire routine from the Coppelia ballet.

Complete coverage: Autism awareness 9 amazing autistic artists with savant syndrome Top 10 toys and gifts for children with autism

The 10-year-old is diagnosed with both autism and DiGeorge syndrome, a genetic disorder.

According to the Mayo Clinic, DiGeorge syndrome is a disorder caused by a chromosome 22 defect that leads to poor development of different body systems. The syndrome is normally associated with heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood and behavioral disorders. According to a National Institute of Health study, prevalence is estimated at 14.1 affected patients per 100,000 live births.

About 1 in 88 children are diagnosed with an autism spectrum disorder, which are rooted in problems with behavior, communication and socialization. The rate jumps to 1 in 54 when it comes to boys.

Bergs was diagnosed with the conditions following her birth on June 24, 2002 according to her official Facebook page Clara's Happy Thumbs. She spent her first 16 months in the hospital, and thanks to multiple therapies, supplements and diets she started walking at the age of 4, talking at the age of 6 and has stayed relatively healthy.

For more videos starring Bergs, visit her YouTube channel.

The rest is here:
Girl diagnosed with autism and DiGeorge syndrome memorizes entire Coppelia ballet

Little evidence supports medical treatment options for adolescents with autism, researchers say

Posted on by

ScienceDaily (Sep. 24, 2012) Vanderbilt University researchers are reporting today that there is insufficient evidence to support the use of medical interventions in adolescents and young adults with autism.

Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population, the researchers said.

These findings are featured in the Sept. 24 issue of Pediatrics.

"We need more research to be able to understand how to treat core symptoms of autism in this population, as well as common associated symptoms such as anxiety, compulsive behaviors and agitation," said Jeremy Veenstra-VanderWeele, M.D., assistant professor of Psychiatry, Pediatrics and Pharmacology and Vanderbilt Kennedy Center investigator. "Individuals, families and clinicians currently have to make decisions together, often in a state of desperation, without clear guidance on what might make things better and what might make things worse, and too often, people with autism spectrum disorders end up on one or more medications without a clear sense of whether the medicine is helping."

This research is part of a larger report on interventions for adolescents and young adults with autism that found there is little evidence to support findings, good or bad, for all therapies currently used.

The researchers systematically screened more than 4,500 studies and reviewed the 32 studies published from January 1980 to December 2011 on therapies for people ages 13 to 30 with autism spectrum disorders. They focused on the outcomes, including harms and adverse effects, of interventions, including medical, behavioral, educational and vocational.

Key findings:

Although the prevalence of autism is on the rise, much remains to be discovered when it comes to interventions for this population, the researchers concluded.

As recently as the 1970s, autism was believed to affect just one in 2,000 children, but newly released data from the Centers for Disease Control and Prevention (CDC) estimates that one in 88 children has an autism spectrum disorder. Boys with autism outnumber girls 5-to-1, which estimates that one in 54 boys in the United States has autism.

Additional investigators on this report include Melissa McPheeters, Ph.D., MPH, director of Vanderbilt's Evidence-Based Practice Center and senior author; Zachary Warren, Ph.D., director of the Vanderbilt Kennedy Center's Treatment and Research Institute for Autism Spectrum Disorders; Julie Lounds Taylor, Ph.D., assistant professor of Pediatrics and Special Education and lead author; Dwayne Dove, M.D., Ph.D., fellow in Developmental-Behavioral Pediatrics; Nila Sathe, M.S., M.L.I.S., program manager, Institute for Medicine and Public Health; and Rebecca Jerome, M.L.I.S., MPH, assistant director, Eskind Biomedical Library.

Read the original here:
Little evidence supports medical treatment options for adolescents with autism, researchers say

Little Evidence Supports Medical Treatment Options for Adolescents with Autism

Posted on by

To view this release online, visit http://news.vanderbilt.edu/2012/09/little-evidence-supports-medical-treatment-options-for-adolescents-with-autism/.

Newswise Vanderbilt University researchers are reporting today that there is insufficient evidence to support the use of medical interventions in adolescents and young adults with autism.

Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population, the researchers said.

These findings are featured in the Sept. 24 issue of Pediatrics.

We need more research to be able to understand how to treat core symptoms of autism in this population, as well as common associated symptoms such as anxiety, compulsive behaviors and agitation, said Jeremy Veenstra-VanderWeele, M.D., assistant professor of Psychiatry, Pediatrics and Pharmacology and Vanderbilt Kennedy Center investigator. Individuals, families and clinicians currently have to make decisions together, often in a state of desperation, without clear guidance on what might make things better and what might make things worse, and too often, people with autism spectrum disorders end up on one or more medications without a clear sense of whether the medicine is helping."

This research is part of a larger report on interventions for adolescents and young adults with autism that found there is little evidence to support findings, good or bad, for all therapies currently used.

The researchers systematically screened more than 4,500 studies and reviewed the 32 studies published from January 1980 to December 2011 on therapies for people ages 13 to 30 with autism spectrum disorders. They focused on the outcomes, including harms and adverse effects, of interventions, including medical, behavioral, educational and vocational.

Key findings:

Some evidence revealed that treatments could improve social skills and educational outcomes such as vocabulary or reading, but the studies were generally small and had limited follow-up.

Limited evidence supports the use of medical interventions in adolescents and young adults with autism. The most consistent findings were identified for the effects of antipsychotic medications on reducing problem behaviors that tend to occur with autism, such as irritability and aggression. Harms associated with medications included sedation and weight gain.

Follow this link:
Little Evidence Supports Medical Treatment Options for Adolescents with Autism

Research lacking on drugs for older children with autism

Posted on by

By Serena Gordon HealthDay Reporter

MONDAY, Sept. 24 (HealthDay News) -- More and more children are growing up with autism, and although many treatments and interventions are now available, clinical studies on the use of medications in teens and young adults are lacking, according to new research.

"The majority of (older) individuals with autism spectrum disorders appear to be taking medications that we have very little evidence for," said the study's lead author, Dr. Jeremy Veenstra-VanderWeele, medical director of the Treatment and Research Institute for Autism Spectrum Disorders at the Vanderbilt Brain Institute in Nashville, Tenn.

"In the absence of sufficient evidence, parents and people with autism should find a clinician who tells you what's known and unknown about the potential benefits and risks of any medication," he said. "It should be a shared decision-making process."

Results of the study were published online on Sept. 24 in the journal Pediatrics.

Autism spectrum disorders are neurodevelopmental disorders that impair social development and communication. Autism spectrum disorders also may cause repetitive movements and even self-abusive behavior, such as head banging, according to the U.S. National Institute of Neurological Disorders and Stroke (NINDS).

It is estimated that about one in 88 American children has been identified with an autism spectrum disorder

As children with autism age, some do experience significant improvements, according to NINDS, but many do not. There is no cure for autism, although there are many treatments available, including education and behavioral interventions and medications.

Medications usually are used to treat some of the symptoms associated with autism, rather than the core symptoms of the condition, according to background information in the new study. For example, the medication risperidone (brand name Risperdal) may be used to treat behavioral symptoms associated with autism, such as aggression, outbursts and irritability, said Dr. Melissa Nishawala, medical director of the Autism Spectrum Disorders Clinical and Research Program at the NYU Child Study Center in New York City.

"Medications like risperidone and aripiprazole don't address the cause of autism, but they help calm down [people with autism]," Veenstra-VanderWeele said.

Read more here:
Research lacking on drugs for older children with autism

Autism After 16 Begins Series on Mental Health and Autism

Posted on by

Roanoke, VA (PRWEB) September 24, 2012

Autism After 16 today published the first in a series of articles on autism and mental health.

When Autism and Mental Health Issues Collide focuses on challenges faced by teens and adults with autism who simultaneously experience mental illness. While studies indicate that a number of adults with autism also face mental health challenges, accurately assessing the presence of a comorbid conditionone that exists alongside the autism diagnosiscan be difficult. Often behavioral challenges are considered to be part of the autism diagnosis, when mental illness is actually present.

We have so much more to learn about the parameters of autism, its hard to know at what point a person should receive an additional diagnosis, says Dr. Ken Duckworth, medical director at the National Alliance on Mental Illness. But there are people who have all of the symptoms of a mental illness in addition to the autism that warrant additional diagnoses.

When comorbid conditions arent accurately diagnosed, treatment becomes difficult. The Autism After 16 article shares the story of a young man whose comorbid mental illness began to threaten his well-being and that of his family. Coping with mental illness in addition to autism can be extremely complicated, notes editor Merope Pavlides. The individual suffers, and so does the family. We want to help drive dialogue about this issue and to encourage families to seek help. And to know that they are not alone.

Written by Florida-based journalist Cara Nissman, When Autism and Mental Health Issues Collide is the first of several articles on mental health that Autism After 16 will publish. The next one will examine mental health concerns in college support programs for students with autism.

Autism After 16 is a website devoted to providing information and analysis of adult autism issues. Over 50 percent of its contributing writers are autistic adults, while many others are family members. Autism After 16 provides informational articles on accessing adult services, commentary, links to useful resources, and a library of videos to help teach independent living skills.

Go here to see the original:
Autism After 16 Begins Series on Mental Health and Autism

NYU Langone Medical Center Collaborates on Groundbreaking International Initiative to Advance Autism Research

Posted on by

NEW YORK--(BUSINESS WIRE)--

NYU Langone Medical Center announced today the creation of a new groundbreaking collaboration in autism research. The Autism Brain Imaging Data Exchange (ABIDE) is a database of brain scans from more than 15 leading international research institutions and academic medical centers. ABIDE was designed to advance scientific understanding of Autism Spectrum Disorder (ASD) by allowing researchers to share autism data within the broader scientific community. The collaboration is led by NYU Langone, coordinator of ABIDE and the single largest contributor of research to the consortium, and Kennedy Krieger Institute.

This collaboration fills an unmet need among the autism research community. By providing access to an unprecedented large-scale dataset, ABIDE has the potential to move autism research forward andthus advance our understanding of a complex disorder, said Adriana Di Martino, MD, co-founder and coordinator of ABIDE and Leon Levy assistant professor of child and adolescent psychiatry at the Child Study Center at NYU Langone Medical Center. We are honored that some of the worlds leading institutions have contributed data and truly feel this initiative will help to change the face of autism research. This is only the beginning.

According to the Centers for Disease Control and Prevention, one in every 88 children in the U.S. is diagnosed with an Autism Spectrum Disorder by age 8. A key focus area for autism research is brain imaging to map out the pathology of disease, which can lead to important new understandings about the function and structures of the brain.

ABIDE was created to facilitate and advance autism research and is expected to contribute to increasing collaboration within the autism research community. ABIDE currently includes brain images from more than 1,000 individuals, ages 6 to 64 years old, aggregated from more than 15 leading medical and research institutions around the world.

Acquiring imaging data in children with autism can be challenging. By establishing a collaborative environment for data sharing, ABIDE helps us overcome obstacles and will undoubtedly lead to progress in understanding brain structure and function in autism, said Dr. Stewart Mostofsky, co-founder of ABIDE and Director of the Laboratory for Neurocognitive and Imaging Research at Kennedy Krieger Institute. This is a vital demonstration of how the scientific community can become more cooperative and, by working together, increase our knowledge to help improve autism diagnosis and treatment.

ABIDE represents an unparalleled resource for researchers and clinicians in the autism field, according to Glenn Saxe, MD, the Arnold Simon Professor and Chair of the Department of Child and Adolescent Psychiatry, and director of the Child Study Center at NYU Langone.

The magnitude of this initiative cannot be overstated as it may potentially change the landscape of autism research, advance the discovery of diagnostic tools and treatments and most importantly, ultimately help us provide the highest level of patient care to children with this debilitating disorder, he added. We hope the ABIDE initiative will become a model for other research areas, as innovation drives the advancement of ideas.

The Child Study Center (CSC) at NYU Langone Medical Center is a recognized leader in the treatment of child psychiatric disorders through scientific practice, research, and education. The CSC offers a wide range of mental health services for children, adolescents, young adults and families and our experts specialize in the fields of child, adolescent and adult psychiatry, clinical psychology, neuropsychology, social work, pediatric neurology and education and academic achievement. The center recently moved to their new location at One Park Ave. in Manhattan and has facilities in New Jersey and on Long Island. For more information, please visit the Child Study Center website or call (212) 263-6622.

About NYU Langone Medical Center

Read more from the original source:
NYU Langone Medical Center Collaborates on Groundbreaking International Initiative to Advance Autism Research

Therapeutic impact of cell transplantation aided by magnetic factor

Posted on by

Public release date: 24-Sep-2012 [ | E-mail | Share ]

Contact: David Eve celltransplantation@gmail.com Cell Transplantation Center of Excellence for Aging and Brain Repair

Putnam Valley, NY. (Sept. 24, 2012) Two studies in the current issue of Cell Transplantation (21:6), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, demonstrate how the use of magnetic particles are a factor that can positively impact on the targeted delivery of transplanted stem cells and to also provide better cell retention.

A research team from the University of British Columbia used focused magnetic stem cell targeting to improve the delivery and transport of mensenchymal stem cells to the retinas of test rats while researchers from Cedars-Sinai Heart Institute (Los Angeles) injected magnetically enhanced cardiac stem cells to guide the cells to their target to increase cell retention and therapeutic benefit in rat models of ischemic/reperfusion injury.

According to study co-author Dr. Kevin Gregory-Evans, MD, PhD, of the Centre for Macular Degeneration at the University of British Columbia, degeneration of the retina - the cause of macular degeneration as well as other eye diseases - accounts for most cases of blindness in the developed world. To date, the transplantation of mensenchymal stem cells to the damaged retina has had "limited success" because the cells reaching the retina have been in "very low numbers and in random distribution."

Seeking to improve stem cell transplantation to the retina, the researchers magnetized rat mesenchymal stem cells (MSCs) using superparamagnetic iron oxide nanoparticles (SPIONs). Via an externally placed magnet, they directed the SPION enhanced cells to the peripheral retinas of the test animals.

"Our results showed that large numbers of blood-borne magnetic MSCs can be targeted to specific retinal locations and produce therapeutically useful biochemical changes in the target tissue," explained Gregory-Evans. "Such an approach would be optimal in focal tissue diseases of the outer retina, such as age-related macular degeneration."

Contact:

Dr. Kevin Gregory-Evans, Centre for Macular Research, Department of Ophthalmology and Visual Sciences, University of British Columbia, 2550 Willow St., Vancouver, BC, Canada, V5Z 3N9 Tel. + 1-604-671-0419 Fax. + 1-604-875-4663 Email: kge30@interchange.unc.ca

Citation: Yanai, A.; Hfeli, U. O.; Metcalfe, A. L.; Soema, P.; Addo, L.; Gregory-Evans, C. Y.; Po, K.; Shan, X.; Moritz, O. L.; Gregory-Evans, K. Focused Magnetic Stem Cell Targeting to the Retina Using Superparamagnetic Iron Oxide Nanoparticles. Cell Transplant. 21(6):1137-1148; 2012.

Go here to read the rest:
Therapeutic impact of cell transplantation aided by magnetic factor

BIO Announces Therapeutic Workshops for 11th Annual BIO Investor Forum

Posted on by

WASHINGTON--(BUSINESS WIRE)--

The Biotechnology Industry Organization (BIO) announces Therapeutic Workshops on Cancer stem cell therapy, kinase drugs, and ultra rare diseases planned for the upcoming BIO Investor Forum. Hosted by BIO, the 11th annual event will take place at the Palace Hotel on October 9-10 in San Francisco, Calif.

This years Therapeutic Workshops will address some of the most exciting therapeutic advances for the biotech industry. We have worked very closely with this years esteemed Advisory Committee to identify topics that will engage investors and industry alike, said Alan Eisenberg, executive vice president, Emerging Companies & Business Developmentat BIO.

Therapeutic Workshops will feature senior-level industry executives, scientific officers and leading clinical experts that represent innovative investment opportunities in the biotech industry.

Therapeutic Workshops include:

The BIO Investor Forum features public and venture-stage company presentations, expert-led, business roundtables, one-on-one investor meetings and networking opportunities.

To learn more about the BIO Investor Forum, including registration and program information, please visit here. Advance media registration is available here. Registration is complimentary for credentialed members of the media and qualified investors.

BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors including Supporting Bank Stifel, Nicolaus & Company. BIO Double Helix and Helix Sponsors include Abbott Biotech Ventures, Amgen Ventures, Baxter Ventures, J&J Development Corporation, MedImmune Ventures, GlaxoSmithKline, Merck and Pfizer.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the worlds largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling innovations transforming our world. Subscribe to BIOtechNOW.

Excerpt from:
BIO Announces Therapeutic Workshops for 11th Annual BIO Investor Forum

West county community briefs: Parkinson's disease lecture to be offered

Posted on by

CAMARILLO

Parkinson's disease lecture to be offered

A presentation on Parkinson's disease will provide individuals with information about current opportunities for clinical trials in Ventura County. This free presentation will be offered Tuesday 1-3 p.m. at the Camarillo Health Care District, 3639 E. Las Posas Road.

A question and answer period will follow the lecture.

For more information or to register, call 388-1952, ext. 100.

Speaker to discuss family harmony

Caroline Prijatel-Sutton will speak at the Soroptimist International of Camarillo meeting from 7:30-8:30 a.m. Thursday at Ric's Restaurant, 2500 Las Posas Road.

Prijatel-Sutton is the executive director of the Coalition of Family Harmony.

The nonprofit provides direct services to victims of domestic violence, helps prevent the cycle of violence and sexual assault and educates the community on violence against women, children and men.

For information on the coalition, visit http://www.thecoalition.org. For more information, visit http://www.soroptimistcamarillo.org. Breakfast is $15. Call 987-4053 to make a reservation.

See the original post:
West county community briefs: Parkinson's disease lecture to be offered

West county community briefs: Parkinson’s disease lecture to be offered

Posted on by

CAMARILLO

Parkinson's disease lecture to be offered

A presentation on Parkinson's disease will provide individuals with information about current opportunities for clinical trials in Ventura County. This free presentation will be offered Tuesday 1-3 p.m. at the Camarillo Health Care District, 3639 E. Las Posas Road.

A question and answer period will follow the lecture.

For more information or to register, call 388-1952, ext. 100.

Speaker to discuss family harmony

Caroline Prijatel-Sutton will speak at the Soroptimist International of Camarillo meeting from 7:30-8:30 a.m. Thursday at Ric's Restaurant, 2500 Las Posas Road.

Prijatel-Sutton is the executive director of the Coalition of Family Harmony.

The nonprofit provides direct services to victims of domestic violence, helps prevent the cycle of violence and sexual assault and educates the community on violence against women, children and men.

For information on the coalition, visit http://www.thecoalition.org. For more information, visit http://www.soroptimistcamarillo.org. Breakfast is $15. Call 987-4053 to make a reservation.

See the original post:
West county community briefs: Parkinson's disease lecture to be offered

Dancing through Parkinson's

Posted on by

Written by Karen Kovacs Dydzuhn Friday, 21 September 2012 10:30

Although people diagnosed with Parkinson's disease face many physical challenges, this oft debilitating illness cannot rob its victims of the joy of dancing. Moreover, when patients engage in creative movements set to music on a regular basis, there are inevitably great improvements to their overall physicality and brain functions.

Recent research has shown a strong correlation between dancing and short- and long- improvements in the range of motion, gait, balance, hand movements and rigidity in facial muscles for those diagnosed with Parkinson's disease, said Dr. J. Antonelle de Marcaida of Eastern Connecticut Neurology Specialists.

Marcaida led a discussion about the relationship between dance and Parkinson's disease during the Mark Morris Dance Group's Dance for PD program at Fairfield University.

Led by David Leventhal of the Mark Morris Dance Group, more than 50 individuals with Parkinson's and their care partners participated in two dance sessions at Fairfield's Quick Center for the Arts. A company dancer for 14 years, Leventhal is pleased to devote himself full time to this program since his retirement last year. Since 2011, Dance for PD classes have been held in the United States and abroad.

"The dancers in the class are so eager to learn, so open and so courageous to the way they approach the movements," Leventhal explained.

After the Mark Morris Dance Group performed to an enthusiastic crowd at the Quick Center Saturday, the company's founder, Mark Morris, answered questions from the audience. About Dance for PD, Morris said those with Parkinson's disease do not leave the dance class feeling the way they did when they first walked in the doors of the Brooklyn studio.

"It's a 'fix' in that they want more of it," Morris said.

Accompanied by a pianist playing an eclectic mix of music show tunes, standards and classical participants begin the class in a seated position. Leventhal said that if they chose, they could experience the entire class in the chair.

"This is a dance class and we are here to have fun," he said. "And, you know your bodies best. So, if something doesn't feel right, don't do it, or modify it."

See original here:
Dancing through Parkinson's